VanEck Intermediate Muni ETF

Telix Pharmaceuticals Targets $1.5B Revenue as ITM Deal Speeds Therapy Push

MarketBeat•5d ago

Telix Pharmaceuticals: The ITM Deal Could Strengthen The Long-Term Buy Case

Seeking Alpha•17d ago

Correction: ITM and Lumara Bio Announce Dose-Response Analysis for ¹⁷⁷Lu-edotreotide (ITM-11) and Data Supporting Early-Stage Pipeline at EANM 2026

Globe News Wire•19d ago

ITM and Lumara Bio Announce Dose-Response Analysis for ¹⁷⁷Lu-edotreotide (ITM-11) and Data Supporting Early-Stage Pipeline at EANM 2026

GlobeNewsWire•19d ago

ITM Power cuts annual losses as revenue rises 68%

Proactive Investors•21d ago

ITM Power's Hydropulse signs terms for 150 MW green hydrogen project

Proactive Investors•28d ago

ITM Power rises 5% on loss outlook as Peel Hunt keeps 'hold'

Proactive Investors•1mo ago

ITM Power upgrades 2026 loss guidance ahead of results

Proactive Investors•1mo ago

Titan International Signs Definitive Agreement to Sell ITM Business to USCO S.p.A.

PRNewsWire•1mo ago

Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse

GlobeNewsWire•1mo ago

Australia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion

Reuters•1mo ago

Getting Paid to Extend: The Case for Muni Duration

ETF Trends•2mo ago